News
News
Databases & Sample Sharing
Biobank and Sample Sharing​
As part of the Networking Activities of the TRANSVAC2 project, a database of the types of sample collections available at partner institutes has been established. These collections include different animal study derived products (sera, tissues etc.), mainly involving a biohazard level 3 or 4 for mice, NHP and non-rodent animals. These collections will continue to be developed during the project lifetime. Interested applicants are encouraged to contact directly TRANSVAC partner or transvacinvo@euvaccine.eu. ​
Overview of materials available through TRANSVAC2 The list is not exhaustive and its purpose is to initiate an individual discussion between a potential user and TRANSVAC partner (sample type, IP issues should be arranged case by case basis).
TRANSVAC2 and other biobank projects
There are several other biobank networks/projects – funded by the EU or other bodies – which TRANSVAC2 is aware of and will be listed in this section. TRANSVAC2 and its partners support these networks/projects, encourage researchers to use them and do not intend to offer materials which are already available through existing biobanks:
Regulatory Support Databases
​
TRANSVAC2 Partner, ECRIN (European Clinical Trial Research Infrastructure Network) makes available a resource for information about clinical trial regulatory and ethical requirements covering 22 European countries and multiple study types such as clinical drug trials, clinical investigations of medical devices, combination drug-device studies and nutritional studies.
​
TRANSVAC2 Partner, EATRIS (European infrastructure for translational medicine) makes available a Regulatory Information system database. Potential users of the database shall contact EATRIS via link bellow.
​
Alternative Methods to Animal Models
​
TRANSVAC seeks to contribute to the 3Rs (Replacement, Reduction and Refinement) principle by providing the scientific community with Open Science tools and information to identify, develop and use 3R-based technologies to validate human and veterinary vaccines. Descriptions and information on non-animal methods are collected below.